Sartorius Stedim Biotech Investor Relations Service
Sartorius Stedim Biotech's investor relations service focuses on maintaining an ongoing, open dialogue with shareholders, potential investors and financial analysts. We strive to ensure the highest possible level of transparency and provide shareholders and the interested general public alike with equal and timely access to information relevant to our share prices.
Offer to acquire TAP Biosystems Group plc
On October 7, 2013, the Sartorius Group has announced an offer to acquire the UK company TAP Biosystems Group plc.
Nine-Month Figures of 2013
Strong growth in order intake and sales revenue | Overproportionate increase in profitability | All key financial indicators at comfortable levels | Guidance confirmedDate: 21.10.2013 Category: Sartorius Stedim Biotech
Sartorius Stedim Biotech and BD Diagnostics Strengthen Cooperation in the Area of Microbiological Diagnostics
Expansion of product portfolio for microbiological analyses in the labDate: 16.10.2013 Category: Sartorius Stedim Biotech
Sartorius Stedim Biotech to further expand its portfolio of single-use fermentorsDate: 07.10.2013 Category: Sartorius Stedim Biotech
Conveniently see at one glance the performance of our shares. more
October 21, 2013
Publication of nine-month figures for 2013
Publication of preliminary figures for fiscal 2013
Annual General Shareholders' Meeting in Aubagne, France
April 8, 2014